Global Blood Filtering Device Market 2021 Applications, Market Size According to a Specific Product, Sales and Revenue by Region 2027 [MarketWatch]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: MarketWatch
Research Report 2021-2027 which includes accurate analysis at global, regional, and country levels along with a forecast analysis. The report covers critical market information on market size, growth rates, and forecasts in key regional and country markets along with growth opportunities in the market. The report provides a comprehensive view of the global Blood Filtering Device market and detailed value chain analysis to help players closely understand important changes in business activities observed across the industry. There is a deep segmental analysis of the global Blood Filtering Device market where key product and application segments. Also, the readers are provided with actual market figures related to the size of the global market in terms of value and volume for the forecast period 2021-2027. The information included in the report is made with rigorous primary and secondary research and demonstrated research techniques. DOWNLOAD FREE SAMPLE REPORT: https://www.marketand
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- HiberCell Announces First Patient Dosed in Clinical Collaboration with Merck, Evaluating HC-7366 in Combination with WELIREG® (belzutifan) in patients with advanced ccRCC [Yahoo! Finance]Yahoo! Finance
- Global Impact, on behalf of the Advancing Health Online Initiative (AHO) and Gavi, The Vaccine Alliance, invests $12 million through the VaxSocial Initiative to implement innovative social media interventions to build vaccine confidence [Yahoo! Finance]Yahoo! Finance
- Jemperli contends with blockbuster Keytruda in endometrial cancer [Yahoo! Finance]Yahoo! Finance
- Merck Keytruda combo meets main goal in late-stage trial for advanced gastric cancer [Seeking Alpha]Seeking Alpha
- Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 4/25/24 - Beat
MRK
Sec Filings
- 4/25/24 - Form 8-K
- 4/11/24 - Form ARS
- 4/11/24 - Form DEFA14A
- MRK's page on the SEC website